About
Profile
Sarepta Therapeutics is a U.S. commercial-stage biopharmaceutical company focused on the discovery and development of unique RNA-targeted therapeutics for the treatment of rare neuromuscular diseases.
Headquarters
Intraday
High
-
Low
-
52-week
High
-
Low
-
SRPT
Shares plunged 35% after the biotechnology company said a late-stage study testing two gene-targeted therapies for Duchenne muscular dystrophy did not meet the main goal.
...
Available for logged in users only.
The multiple price alert feature will smartly add or remove $1 if your alert was hit.
It's only available if you are logged in, a V.I.P. member or if you are using the AI chrome extension.
Contact us via Twitter if you are interested in trying it out.
- Elanco Animal Health set to join S&P MidCap 400, Sarepta to join S&P SmallCap 600
- Sarepta Therapeutics refinances $700M of convertible notes
- Sarepta sells Arrowhead stock, activates $100M milestone payment
- Biotech sector slips amid reported return of ousted FDA official
- Sarepta Therapeutics Q2 2025 Earnings Preview
- Sarepta rises on strong quarterly earnings and revenue
- Sarepta Therapeutics Non-GAAP EPS of $2.02 beats by $0.86, revenue of $611.1M beats by $80.06M
- Sarepta reportedly hired Trump-linked lobbying firm after gene therapy deaths
- Notable analyst calls this week: Nike, Microsoft and Sarepta among top picks
- FDA vaccines head, chief medical officer Vinay Prasad departs agency
- Sarepta, Replimmune, Capricor rise as FDA’s biologics head departs
- Sarepta upgraded to Neutral at J.P. Morgan, Outperform at Oppenheimer
- FDA recommends lifting voluntary hold on Elevidys in ambulatory patients
- Sarepta rises 2%; Barclays downgrades to underweight on liquidity and Elevidys concerns
- Arrowhead Pharmaceuticals earns $100M milestone from Sarepta Therapeutics
- What’s behind Sarepta’s gene therapy deaths?
- Sarepta denies Elevidys is linked to latest patient death in Brazil
- Sarepta falls as FDA plans to investigate death of child who received Elevidys
- Biggest stock movers Friday: INTC, PARA, SRPT, and more
- EU panel declines backing Sarepta-Roche gene therapy for Duchenne
Earnings History
| Date | EPS / Forecast | Revenue / Forecast | |
|---|---|---|---|
| October 27, 2021 | - / -1.83 | - / 171.36M | |
| August 4, 2021 | -1.02 / -1.3 | 164.09M / 167.07M | |
| May 5, 2021 | -2.1 / -1.83 | 146.93M / 145.81M |
Beat! |
| March 1, 2021 | -2.4 / -1.8 | 145.14M / 150.38M | |
| November 5, 2020 | -2.5 / -1.71 | 143.92M / 137.76M |
Beat! |
| August 5, 2020 | -1.93 / -1.72 | 137.36M / 116.29M |
Beat! |
| May 6, 2020 | -0.23 / -1.92 | 113.67M / 116.49M | |
| February 26, 2020 | -3.16 / -1.81 | 100.11M / 98.8M |
Beat! |
| November 7, 2019 | -1.7 / -1.35 | 99.04M / 98.48M |
Beat! |
| August 7, 2019 | -3.74 / -1.07 | 94.67M / 91.05M |
Beat! |
| May 8, 2019 | -1.07 / -1.61 | 87.01M / 86.6M |
Beat! |
| February 27, 2019 | -2.05 / -1.02 | 84.42M / 84.92M | |
| October 24, 2018 | -1.15 / -0.78 | 78.49M / 78.75M | |
| August 8, 2018 | -1.67 / -0.84 | 73.53M / 71.4M |
Beat! |
| May 3, 2018 | -0.55 / -0.32 | 64.6M / 65.09M | |
| February 26, 2018 | - / -0.32 | - / 55.57M | |
| October 25, 2017 | -0.76 / -0.85 | 45.95M / 40.77M |
Beat! |
| July 19, 2017 | -0.46 / -0.77 | 35.01M / 22.38M |
Beat! |
| April 27, 2017 | -0.71 / -0.81 | 16.34M / - |
Beat! |
| February 28, 2017 | -0.71 / -0.45 | 5.42M / 46.83M | |
| October 27, 2016 | -1.18 / -0.52 | - / 3.08M |
| Date | Price | Open | High | Low | Vol | Change | |||
|---|---|---|---|---|---|---|---|---|---|
| Dec 2 | 20.47 | 19.82 |
20.53
|
19.37
|
4.0M | 3.80% | |||
| Dec 1 | 19.72 | 20.84 |
21
|
19.67
|
2.9M | -7.59% | |||
| Nov 28 | 21.34 | 21.12 |
21.38
|
20.72
|
1.6M | 1.86% | |||
| Nov 26 | 20.95 | 19.4 |
21.21
|
19.35
|
3.2M | 8.27% | |||
| Nov 25 | 19.35 | 18.91 |
19.45
|
18.73
|
3.0M | 2.33% | |||
| Nov 24 | 18.91 | 17.76 |
19.14
|
17.61
|
4.4M | 6.90% | |||
| Nov 21 | 17.69 | 16.4 |
17.72
|
16.33
|
3.9M | 7.34% | |||
| Nov 20 | 16.48 | 16.69 |
17.6
|
16.31
|
4.6M | 0.55% | |||
| Nov 19 | 16.39 | 17.41 |
17.43
|
15.94
|
4.4M | -6.02% | |||
| Nov 18 | 17.44 | 17.38 |
17.73
|
16.94
|
3.7M | -0.57% | |||
| Nov 17 | 17.54 | 18.61 |
18.7
|
17.38
|
4.5M | -6.75% | |||
| Nov 14 | 18.81 | 17.51 |
20.15
|
17.51
|
8.0M | 5.56% | |||
| Nov 13 | 17.82 | 17.69 |
18.35
|
17.5
|
3.5M | -1% | |||
| Nov 12 | 18 | 18.05 |
18.63
|
17.6
|
4.1M | 0.11% | |||
| Nov 11 | 17.98 | 17.27 |
18.3
|
16.9
|
4.4M | 4.11% | |||
| Nov 10 | 17.27 | 18.13 |
18.13
|
17.26
|
3.5M | -2.04% | |||
| Nov 7 | 17.63 | 17.77 |
17.95
|
16.55
|
4.2M | -0.06% | |||
| Nov 6 | 17.64 | 18.64 |
18.75
|
17.41
|
6.6M | -5.52% | |||
| Nov 5 | 18.67 | 16.59 |
18.8
|
16.58
|
11.1M | 15.25% | |||
| Nov 4 | 16.2 | 15.24 |
17.75
|
15.08
|
23.9M | -33.74% | |||
| Nov 3 | 24.45 | 24.27 |
24.55
|
22.67
|
15.6M | 1.83% | |||
| Oct 31 | 24.01 | 23.42 |
24.48
|
23.02
|
4.5M | 3.27% | |||
| Oct 30 | 23.25 | 23.22 |
23.39
|
22.79
|
3.4M | -0.85% | |||
| Oct 29 | 23.45 | 24.02 |
24.09
|
23.15
|
3.7M | -3.18% | |||
| Oct 28 | 24.22 | 23.48 |
24.4
|
23.27
|
3.4M | 3.06% | |||
| Oct 27 | 23.5 | 23.28 |
24.24
|
23.06
|
4.0M | 3.02% | |||
| Oct 24 | 22.81 | 21.94 |
23.43
|
21.8
|
3.7M | 4.20% | |||
| Oct 23 | 21.89 | 21.8 |
22.27
|
21.29
|
4.5M | -2.58% | |||
| Oct 22 | 22.47 | 23.2 |
23.72
|
22.29
|
3.7M | -3.77% | |||
| Oct 21 | 23.35 | 23.07 |
23.54
|
22.77
|
2.9M | 1.30% | |||
| Oct 20 | 23.05 | 23 |
23.73
|
22.8
|
4.0M | 2.40% | |||
| Oct 17 | 22.51 | 22.83 |
22.99
|
21.93
|
4.5M | -3.56% | |||
| Oct 16 | 23.34 | 22.25 |
23.87
|
22.22
|
6.1M | 5.14% | |||
| Oct 15 | 22.2 | 21.74 |
22.26
|
21.52
|
3.5M | 3.59% | |||
| Oct 14 | 21.43 | 21.58 |
21.82
|
20.92
|
3.7M | -2.41% | |||
| Oct 13 | 21.96 | 22 |
22.48
|
21.5
|
4.0M | -0.68% | |||
| Oct 10 | 22.11 | 23.15 |
23.19
|
22.09
|
4.6M | -4.41% | |||
| Oct 9 | 23.13 | 23.44 |
24.18
|
23.05
|
5.3M | -1.07% | |||
| Oct 8 | 23.38 | 24.18 |
25.32
|
22.64
|
10.5M | 1.12% | |||
| Oct 7 | 23.12 | 23.36 |
23.88
|
22.56
|
4.8M | -0.6% | |||
| Oct 6 | 23.26 | 23.15 |
23.59
|
22.31
|
6.2M | 2.74% | |||
| Oct 3 | 22.64 | 22.37 |
22.95
|
21.82
|
8.3M | 1.30% | |||
| Oct 2 | 22.35 | 19.57 |
23.42
|
19.57
|
15.4M | 15.68% | |||
| Oct 1 | 19.32 | 18.88 |
20.05
|
18.88
|
4.7M | 0.26% | |||
| Sep 30 | 19.27 | 18.67 |
19.34
|
18.14
|
5.5M | 2.39% | |||
| Sep 29 | 18.82 | 18.17 |
19.28
|
18.14
|
6.6M | 2.51% | |||
| Sep 26 | 18.36 | 17.64 |
18.39
|
17.57
|
4.1M | 3.61% | |||
| Sep 25 | 17.72 | 18.09 |
18.24
|
17.65
|
4.3M | -2.96% | |||
| Sep 24 | 18.26 | 18.15 |
18.46
|
17.51
|
5.1M | 1.84% | |||
| Sep 23 | 17.93 | 18.72 |
19.05
|
17.88
|
5.6M | -3.86% | |||
| Sep 22 | 18.65 | 18.5 |
19.48
|
18.05
|
9.1M | 7% | |||
| Sep 19 | 17.43 | 18.61 |
18.72
|
17.4
|
6.9M | -5.89% | |||
| Sep 18 | 18.52 | 17.28 |
18.55
|
17.06
|
6.9M | 8.62% | |||
| Sep 17 | 17.05 | 18 |
18.14
|
17.05
|
6.6M | -5.8% | |||
| Sep 16 | 18.1 | 17.86 |
18.84
|
17.76
|
6.4M | 3.61% | |||
| Sep 15 | 17.47 | 17.47 |
18.27
|
17.23
|
5.1M | 0.46% | |||
| Sep 12 | 17.39 | 17.97 |
18.21
|
17.23
|
3.5M | -2.9% | |||
| Sep 11 | 17.91 | 17.2 |
17.95
|
16.85
|
6.1M | 4.01% | |||
| Sep 10 | 17.22 | 17.66 |
17.9
|
17.2
|
5.8M | -2.38% | |||
| Sep 9 | 17.64 | 17.72 |
17.87
|
17.44
|
5.1M | 0% | |||